Klaviyo (KVYO) Chief Legal Officer sells 14,366 shares in 10b5-1 trade
Rhea-AI Filing Summary
Klaviyo, Inc.'s Chief Legal Officer Edmond Landon sold 14,366 shares of Series A Common Stock in an open-market transaction. The sale on March 12, 2026 was at a weighted-average price of $20.15 per share, with individual trade prices ranging from $20.00 to $20.45.
These transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on August 21, 2025. After the sale, Landon holds 312,362 equity-based interests, consisting of 83,955 shares of Series A Common Stock and 228,407 unvested restricted stock units that each represent the right to receive one share upon vesting and settlement.
Positive
- None.
Negative
- None.
Insights
Routine 10b5-1 sale by Klaviyo CLO, small versus remaining stake.
Edmond Landon, Chief Legal Officer of Klaviyo, Inc., executed an open-market sale of 14,366 Series A Common shares at a weighted-average price of $20.15 on March 12, 2026. Trade prices ranged from $20.00 to $20.45 per share.
The sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on August 21, 2025, indicating it was pre-planned rather than opportunistic. Following the transaction, Landon retains 83,955 shares plus 228,407 unvested RSUs, for a total visible position of 312,362 equity interests.
Given the relatively modest number of shares sold compared with his remaining holdings and the 10b5-1 framework, this looks like a routine liquidity event with limited informational value about management’s outlook. Future company filings may provide additional context on any further plan-driven sales.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Series A Common Stock | 14,366 | $20.15 | $289K |
Footnotes (1)
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Consists of (i) 83,955 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 228,407 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.